4277 related articles for article (PubMed ID: 25904081)
1. Parkinson's disease.
Kalia LV; Lang AE
Lancet; 2015 Aug; 386(9996):896-912. PubMed ID: 25904081
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
3. Overview of Parkinson's disease.
Lew M
Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
5. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease.
Béné R; Antić S; Budisić M; Lisak M; Trkanjec Z; Demarin V; Podobnik-Sarkanji S
Acta Clin Croat; 2009 Sep; 48(3):377-80. PubMed ID: 20055267
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease.
Samii A; Nutt JG; Ransom BR
Lancet; 2004 May; 363(9423):1783-93. PubMed ID: 15172778
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in clinical therapeutics: Parkinson's disease.
Erwin WG; Turco TF
Clin Pharm; 1986 Sep; 5(9):742-53. PubMed ID: 3530616
[TBL] [Abstract][Full Text] [Related]
9. [Premotor diagnosis of Parkinson's disease].
Morales-Briceño H; Cervantes-Arriaga A; Rodríguez-Violante M
Gac Med Mex; 2011; 147(1):22-32. PubMed ID: 21412393
[TBL] [Abstract][Full Text] [Related]
10. Milestones in Parkinson's disease--clinical and pathologic features.
Halliday G; Lees A; Stern M
Mov Disord; 2011 May; 26(6):1015-21. PubMed ID: 21626546
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
12. Non-motor symptoms may herald Parkinson's disease.
Khoo TK; Burn DJ
Practitioner; 2009 Sep; 253(1721):19-24, 2. PubMed ID: 19873855
[TBL] [Abstract][Full Text] [Related]
13. [Parkinson's disease: pathogenesis, aetiology, symptoms, diagnostics, and its course].
de Baat C; van Stiphout MAE; Lobbezoo F; van Dijk KD; Berendse HW
Ned Tijdschr Tandheelkd; 2018 Oct; 125(10):509-515. PubMed ID: 30317371
[TBL] [Abstract][Full Text] [Related]
14. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
15. Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations.
Brigo F; Erro R; Marangi A; Bhatia K; Tinazzi M
Parkinsonism Relat Disord; 2014 Aug; 20(8):808-14. PubMed ID: 24935237
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
[TBL] [Abstract][Full Text] [Related]
17. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
[TBL] [Abstract][Full Text] [Related]
18. Overview of mouse models of Parkinson's disease.
Bobela W; Zheng L; Schneider BL
Curr Protoc Mouse Biol; 2014 Sep; 4(3):121-39. PubMed ID: 25723963
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease: genetics and pathogenesis.
Shulman JM; De Jager PL; Feany MB
Annu Rev Pathol; 2011; 6():193-222. PubMed ID: 21034221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
